Analysts Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00

Shares of Prothena Co. plc (NASDAQ:PRTA – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year […]

Leave a Reply

Your email address will not be published.

Previous post Head-To-Head Contrast: Lithium Argentina (LAR) versus Its Rivals
Next post Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) Target Price at $8.39